My Account Log in

2 options

Targeted therapy for cancer / edited by Konstantinos N. Syrigos and Kevin J. Harrington.

Holman Biotech Commons RC271.I45 T37 2003
Loading location information...

Available This item is available for access.

Log in to request item
Levy Dental Medicine Library - Stacks RC271.I45 T37 2003
Loading location information...

Available This item is available for access.

Log in to request item
Format:
Book
Contributor:
Syrigos, Konstantinos N.
Harrington, Kevin J., 1958-
Language:
English
Subjects (All):
Cancer--Treatment.
Cancer.
Immunospecificity.
Cancer--Molecular aspects.
Neoplasms--therapy.
Antibodies, Monoclonal.
Genetic Therapy.
Immunotherapy.
Medical Subjects:
Neoplasms--therapy.
Antibodies, Monoclonal.
Genetic Therapy.
Immunotherapy.
Physical Description:
xviii, 343 pages, 4 unnumbered pages of plates : illustrations (some color) ; 26 cm
Place of Publication:
Oxford ; New York : Oxford University Press, 2003.
Summary:
The quest for therapeutic specificity is implicit in all branches of medicine. In cancer treatment, where the therapeutic modality is a cytotoxic agent such as radiotherapy or chemotherapy, such specificity is of paramount importance. The growing realization that current therapeutic options are likely to yield no more than incremental improvements in outcome has fuelled the search for more active targeted approaches. Targeted Therapy for Cancer discusses the more archetypal systemic targeted therapies, such as those employing monoclonal antibodies or liposomes, but also includes strategies, such as photodynamic therapy and boron neutron capture therapy, that rely on direct physical targeting of disease. The explosion in our understanding of the molecular biology of cancer in recent years has led to the identification of a number of new potential therapeutic targets. These factors, combined with the likelihood that yet more valuable information will be gleaned from the Human Genome Project, mean that significant clinical activity in this arena is anticipated in the coming years, with the very real prospect that gene therapy approaches may find an established role in the standard treatment of some of the common cancers. Targeted Therapy for Cancer brings together the very latest research in this field from an international group of experts and will prove invaluable for molecular oncologists, cancer researchers and those involved with clinical trials, as well as providing a reference for oncologists who are beginning to use some of these therapies in everyday clinical practice.
Contents:
1 The history of targeted therapy for cancer / K.D. Bagshawe 3
2 Preclinical models for the study of targeted therapy / Gail Rowlinson-Busza 17
3 Monoclonal antibody targeting therapy: an overview / Roslyn J. Francis, Richard H.J. Begent 29
4 Antibody-directed enzyme prodrug therapy (ADEPT) / Konstantinos N. Syrigos, Kevin J. Harrington 47
5 Monoclonal antibody targeted radionuclide therapy / Surinder K. Batra, Apollina Goel, Gabriela Pavlinkova, David Colcher 57
6 Combined external beam radiotherapy and radioimmunotherapy / David Raben, Donald J. Buchsbaum 76
7 Genetic immunotherapy for cancer / Hardev S. Pandha 95
8 Targeting of cancer gene therapy / Kevin J. Harrington, Richard G. Vile 111
9 Targeted genetic prodrug activation therapy / Anne Rigg, Hardev S. Pandha 155
10 Antisense therapy as a targeted modality / Justin Waters, David Cunningham 162
11 Dendritic cells
targeting the antitumor immune response / Alan Melcher, Richard G. Vile, Andrew Bateman, Kevin J. Harrington 187
12 Cell carriers for cancer gene therapy: bridging the gap between targeted vectors and systemic delivery? / Rosa Maria Diaz, Heung Chong, Richard G. Vile 204
13 Liposomal targeting of cytotoxic drugs / Kevin J. Harrington, Konstantinos N. Syrigos 224
14 Targeting blood vessels in vivo by using phage display libraries / Claudia Vidal, Marina Cardo-Vila, Johanna Lahdenranta, Wadih Arap, Renata Pasqualini 250
15 Photodynamic therapy / Michael R. Hamblin 259
16 Boron neutron capture therapy: a chemically targeted radiation modality / Gerard M. Morris, Jeffrey A. Coderre 276
17 Cancer immunotherapy directed at growth factor receptors: the ErbB/HER network as a prototype / Michael Sela, Bilha Schecheter, Yosef Yarden 291
18 Targeting the metastatic process / Lloyd A. Culp, Wen-Chang Lin, Nanette R. Kleinman, Priit Kogerman, Raymond Judware, Carson J. Miller, Julianne L. Holleran 317.
Notes:
Includes bibliographical references and index.
ISBN:
0198508964
OCLC:
50055138

The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.

Find

Home Release notes

My Account

Shelf Request an item Bookmarks Fines and fees Settings

Guides

Using the Find catalog Using Articles+ Using your account